Serum promotes vasculogenic mimicry through the EphA2/VE-cadherin/AKT pathway in PC-3 human prostate cancer cells

Life Sciences
Changhwan YeoEun-Ok Lee

Abstract

Serum is widely used for in vitro cell culture of eukaryotic cells. Although serum is well known to affect various biological activities in cancer cells, its effect in vasculogenic mimicry (VM) is not yet fully defined. Thus, this study investigated the role of serum in VM in human prostate cancer (PCa) PC-3 cells. Invasion assay and 3D culture VM tube formation assay are performed. VM-related molecules are checked by western blot and reverse transcriptase-polymerase chain reaction. Nuclear twist is detected by confocal after twist-FITC/DAPI double staining. Serum dramatically induced not only invasion but also VM. Serum increased the phosphorylation of erythropoietin-producing hepatocellular A2 (EphA2) without affecting EphA2 expression. Both the protein and mRNA expression levels of vascular endothelial cadherin (VE-cadherin) are up-regulated by serum. Twist expression was increased in the nucleus by serum. Serum activated AKT through phosphorylation, despite the unchanged AKT expression. Serum caused an increase in matrix metalloproteinase-2 (MMP-2) and laminin subunit 5 gamma-2 (LAMC2) protein expressions. Wortmannin, a phosphoinositide-3-kinase inhibitor, significantly decreased serum-induced invasion and VM. These results...Continue Reading

References

May 1, 1991·Japanese Journal of Cancer Research : Gann·F ImamuraH Akedo
Sep 18, 1997·Journal of the National Cancer Institute·A F Chambers, L M Matrisian
Feb 10, 2000·The American Journal of Pathology·R FolbergA J Maniotis
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Jun 21, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J HendrixR E Seftor
Mar 30, 2002·Science·Lisa M CoussensLynn M Matrisian
Dec 23, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Naohiko KoshikawaVito Quaranta
Dec 23, 2003·Journal of Cellular Biochemistry·Brian Nicholson, Dan Theodorescu
Nov 26, 2004·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Robert Folberg, Andrew J Maniotis
Feb 20, 2007·Cancer Letters·Shiwu ZhangBaocun Sun
Dec 29, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Dietmar Vestweber
Dec 4, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tao SunBao-Cun Sun
Sep 9, 2010·Nature Medicine·Lee M Ellis, Isaiah J Fidler
Dec 17, 2010·World Journal of Gastrointestinal Surgery·Yue-Zu Fan, Wei Sun
Mar 13, 2012·Cancer Biology & Therapy·Ranlu LiuYong Xu
Apr 5, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dawn A KirschmannMary J C Hendrix
Sep 5, 2012·The American Journal of Pathology·Richard E B SeftorMary J C Hendrix
Sep 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zhifei CaoQuansheng Zhou
Oct 23, 2014·Nature Communications·James M DunleaveyAndrew C Dudley
Jan 20, 2015·Journal of Cellular and Molecular Medicine·Lili QiaoYuan Tian
Apr 29, 2016·Oncotarget·Xian ZhaoJianxiu Yu
Jun 22, 2016·Journal of Cancer·Hua WangShaopeng Qiu
Nov 9, 2016·Nature Communications·Stuart C WilliamsonCaroline Dive
Aug 3, 2017·Scientific Reports·Dusan RacordonGareth I Owen
Dec 21, 2017·Reproductive Medicine and Biology·Tatsuma Yao, Yuta Asayama
Apr 20, 2018·International Journal of Molecular Sciences·Yoshiro ItataniYoshiharu Sakai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.